InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Shemesh Shay. Insider active across 1 company, notably Nuvectis Pharma, Inc.. Cumulatively, 6 reports have been logged. Split: 5 buys · 0 sell. Total volume traded: €19k. History available since 4 February 2022. The latest transaction was filed on 20 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
300 shares@ US$16.540.0016% mcap24.1% of flowCommon StockSEC:0001104659-22-063644:0
Ideal exit: 14 Feb 2023 (T+270)
100 shares@ US$19.280.0006% mcap9.5% of flowCommon StockSEC:0001104659-22-062271:0
Ideal exit: 10 Feb 2023 (T+270)
36 shares@ US$14.580.0002% mcap2.6% of flowCommon StockSEC:0001104659-22-059890:0
Ideal exit: 6 Feb 2023 (T+270)
60,000 shares0Common StockSEC:0001104659-22-042814:0
2,100 shares@ US$3.380.0021% mcap31.9% of flowCommon Stock, par value $0.00001SEC:0001104659-22-014375:0
Ideal exit: 1 Nov 2022 (T+270)
2,100 shares@ US$3.38100.0% of flowCommon Stock, par value $0.00001SEC:0001104659-22-014375
Ideal exit: 1 Nov 2022 (T+270)
6 of 6 declarations
About Shemesh Shay
Shemesh Shay is a director at Nuvectis Pharma, Inc.
